Capital Performance Advisors »

Arrivent Biopharma shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6k 67 23.51

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Specialized Funds Div App Etf (VIG)
NVIDIA Corporation (NVDA)

View all positions for Capital Performance Advisors

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Suvretta Capital Management
BlackRock
FMR
Octagon Capital Advisors
Sofinnova Ventures
Infinitum Asset Management
Novo A/S
General Catalyst Group Management
Vanguard Group
State Street Corporation
Sc China Holding
Geode Capital Management
Cormorant Asset Management

View all funds holding Arrivent Biopharma